Earum Pharmaceuticals Ltd
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- ₹1
- Today's High:
- ₹1.04
- Open Price:
- ₹1.03
- 52W Low:
- ₹1
- 52W High:
- ₹3.8
- Prev. Close:
- ₹1.03
- Volume:
- 3844584
Company Statistics
- Market Cap.:
- ₹271.82 million
- Book Value:
- Revenue TTM:
- ₹0
- Operating Margin TTM:
- 0%
- Gross Profit TTM:
- ₹0
- Profit Margin:
- 0%
- Return on Assets TTM:
- 0%
- Return on Equity TTM:
- 379.13%
Company Profile
Earum Pharmaceuticals Ltd had its IPO on under the ticker symbol EARUM.
The company operates in the sector and industry. Earum Pharmaceuticals Ltd has a staff strength of 0 employees.
Stock update
Shares of Earum Pharmaceuticals Ltd opened at ₹1.03 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of ₹1 - ₹1.04, and closed at ₹1.01.
This is a -1.94% slip from the previous day's closing price.
A total volume of 3,844,584 shares were traded at the close of the day’s session.
In the last one week, shares of Earum Pharmaceuticals Ltd have slipped by -3.81%.
Earum Pharmaceuticals Ltd's Key Ratios
Earum Pharmaceuticals Ltd has a market cap of ₹271.82 million, indicating a price to book ratio of 0 and a price to sales ratio of 0.
In the last 12-months Earum Pharmaceuticals Ltd’s revenue was ₹0 with a gross profit of ₹0 and an EBITDA of ₹0. The EBITDA ratio measures Earum Pharmaceuticals Ltd's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Earum Pharmaceuticals Ltd’s operating margin was 0% while its return on assets stood at 0% with a return of equity of 379.13%.
In Q1, Earum Pharmaceuticals Ltd’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.
Earum Pharmaceuticals Ltd’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
Its diluted EPS in the last 12-months stands at ₹0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Earum Pharmaceuticals Ltd’s profitability.
Earum Pharmaceuticals Ltd stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 0.
Earum Pharmaceuticals Ltd stock pays annual dividends of ₹ per share, indicating a yield of None and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- ₹285.84 million
- Total Liabilities
- ₹98.66 million
- Operating Cash Flow
- ₹0.00
- Capital Expenditure
- ₹0
- Dividend Payout Ratio
- 0%
Earum Pharmaceuticals Ltd ended 2024 with ₹285.84 million in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹285.84 million while shareholder equity stood at ₹187.07 million.
Earum Pharmaceuticals Ltd ended 2024 with ₹0 in deferred long-term liabilities, ₹98.66 million in other current liabilities, 123358000.00 in common stock, ₹63.71 million in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹0 and cash and short-term investments were ₹252000.00. The company’s total short-term debt was ₹87,399,000 while long-term debt stood at ₹0.00.
Earum Pharmaceuticals Ltd’s total current assets stands at ₹281.07 million while long-term investments were ₹0 and short-term investments were ₹0. Its net receivables were ₹83.90 million compared to accounts payable of ₹0 and inventory worth ₹131.33 million.
In 2024, Earum Pharmaceuticals Ltd's operating cash flow was ₹0.00 while its capital expenditure stood at ₹0.
Comparatively, Earum Pharmaceuticals Ltd paid ₹0 in dividends in 2024.
Other key metrics
- Current Trading Price
- ₹1.01
- 52-Week High
- ₹3.8
- 52-Week Low
- ₹1
- Analyst Target Price
- ₹
Earum Pharmaceuticals Ltd stock is currently trading at ₹1.01 per share. It touched a 52-week high of ₹3.8 and a 52-week low of ₹3.8. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹1.26 and 200-day moving average was ₹2.08 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 0% of the company’s stock are held by insiders while 0% are held by institutions.